If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
53.00    0.80 (1.53%)
Bid:
53.00
Ask:
53.70
Spread: 0.70 (1.321%)
Market Cap: £335.47m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

28 Nov 2025 12:30

RNS Number : 4869J
Marston's PLC
28 November 2025
 

28 November 2025

 

Notification of interests of directors and persons discharging managerial responsibilities

Marston's PLC (the "Company") announces that on 27 November 2025 the Directors listed below were granted awards over ordinary shares in the Company under the Company's Long Term Incentive Plan (the "Plan").

 

The number of shares over which awards were granted was calculated using the market price at the close of trading on the London Stock Exchange on 27 November 2025, being £0.597 per ordinary share.

 

Awards under the Plan may comprise two elements:

 

(i) a nil-cost option (a "Nil-Cost Option"), and

 

(ii) a CSOP Option over shares with a total value at the date of grant of £60,000 (the statutory limit) with an exercise price of £0.597 per share (a "CSOP Option").

 

The awards will ordinarily vest on the third anniversary of the date of grant to the extent the performance metrics are satisfied. The performance metrics are based on Underlying Profit Before Tax (as regards 40% of the award), Operating Margin (as regards 30% of the award) and Relative Total Shareholder Return (as regards 30% of the award) assessed over the Company's 2026, 2027 and 2028 financial periods, details of which will be set out in the Company's Annual Report and Accounts for the period ended 27 September 2025.

 

To the extent the performance metrics are met, a Nil-Cost Option will be released following a two-year holding period.

 

Linking Arrangement between Nil-Cost Option and CSOP Option

The options granted to Stephen Hopson have been granted such that the maximum pre-tax value delivered to him will not exceed the value of the shares over which the Nil-Cost Option would have vested if it was a standalone option.

 

The CSOP option will be released only to the extent that the aggregate CSOP gain is less than or equal to the value of the shares over which the Nil-Cost Option would be released on the normal released date.

 

Name of individual

Designation

Number of shares subject to CSOP Option

Number of shares subject to Nil-Cost Option

Justin Platt

Director

N/A

1,590,452

Stephen Hopson

Director

100,502

785,175

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

 

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

 

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Stephen Hopson

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of £0.597 per share and a nil-cost option.

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

785,175

CSOP option: £0.597

100,502

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Justin Platt

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

 

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a nil-cost option.

 

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

1,590,452

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAFPAAPSFFA
Date   Source Headline
31st Mar 201510:00 amRNSAcquisition
2nd Mar 20152:58 pmRNSTotal Voting Rights
23rd Feb 20152:01 pmRNSDirectorate Change
2nd Feb 20152:53 pmRNSTotal Voting Rights
28th Jan 201511:59 amRNSResult of AGM
27th Jan 20157:00 amRNSAGM And Trading Statement
13th Jan 201510:09 amRNSBlocklisting Interim Review
6th Jan 20154:51 pmRNSHolding(s) in Company
2nd Jan 201510:37 amRNSTotal Voting Rights
24th Dec 201410:55 amRNSDirector/PDMR Shareholding
18th Dec 20141:46 pmRNSAnnual Financial Report
9th Dec 201410:07 amRNSHolding(s) in Company
1st Dec 20145:24 pmRNSTotal Voting Rights
27th Nov 20147:00 amRNSPreliminary Results
18th Nov 20145:41 pmRNSHolding(s) in Company
3rd Nov 20142:10 pmRNSTotal Voting Rights
8th Oct 20147:00 amRNSYear-end trading update
2nd Oct 201411:19 amRNSTotal Voting Rights
26th Sep 201411:00 amRNSHolding(s) in Company
18th Sep 20149:47 amRNSDirectorate Change
16th Sep 201410:01 amRNSHolding(s) in Company
10th Sep 20149:21 amRNSHolding(s) in Company
9th Sep 20144:51 pmRNSHolding(s) in Company
5th Sep 20147:00 amRNSBoard Appointments
1st Sep 20144:41 pmRNSTotal Voting Rights
1st Aug 20142:52 pmRNSTotal Voting Rights
24th Jul 20147:00 amRNSInterim Management Statement
21st Jul 201412:13 pmRNSHolding(s) in Company
10th Jul 20143:06 pmRNSBlocklisting Interim Review
4th Jul 201410:57 amRNSTotal Voting Rights
1st Jul 20143:56 pmRNSTotal Voting Rights
26th Jun 20143:01 pmRNSDirector/PDMR Shareholding
25th Jun 20142:22 pmRNSHolding(s) in Company
25th Jun 20141:40 pmRNSDirector/PDMR Shareholding
18th Jun 201410:29 amRNSDirector/PDMR Shareholding
3rd Jun 20143:22 pmRNSTotal Voting Rights
19th May 20144:34 pmRNSDirector/PDMR Shareholding
15th May 20147:00 amRNSInterim Results
1st May 20141:12 pmRNSTotal Voting Rights
1st Apr 201411:23 amRNSTotal Voting Rights
3rd Mar 20142:06 pmRNSTotal Voting Rights
28th Feb 201412:22 pmRNSDirector/PDMR Shareholding
27th Feb 201411:40 amRNSHolding(s) in Company
3rd Feb 20143:50 pmRNSTotal Voting Rights
21st Jan 20144:16 pmRNSResult of AGM
21st Jan 20147:00 amRNSAGM and Interim Management Statement
13th Jan 201410:13 amRNSBlocklisting Interim Review
6th Jan 201411:45 amRNSHolding(s) in Company
2nd Jan 20143:47 pmRNSTotal Voting Rights
17th Dec 20134:37 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.